Celik, A. (2024) “Capecitabine monotherapy as first-line treatment in advanced HER2-normal breast cancer – a nationwide, retrospective study”, Acta Oncologica, 63(1), pp. 494–502. doi: 10.2340/1651-226X.2024.38886.